Immuron Limited (IMC)



Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Immuron Limited
Stock Code: IMC
Website: www.immuron.com
GICS Sub-Industry: Pharmaceuticals
Market Cap ($M): 13
Equiv. Shares (M): 75

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
 $ 0.180 $ 0.180 $ 0.180 $ 0.175 $ 0.210 68,500 $ -0.030  -14.286 %

Company Overview

Business Description:
Immuron Limited (IMC) is a biopharmaceutical company focused on oral immunotherapy treatments using dairy-derived antibody products for humans. IMC’s products ranges target infectious diseases of the gastrointestinal tract, chronic diseases such as fatty liver/NASH, and influenza. IMC has one product in the market, Travelan, for preventing travellers’ diarrhoea and seven products under research and development process.


Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014  A -2.5 -6.1 -- 0.0 0.0 0.0 --
2013  A -3.5 -24.9 -- 0.0 0.0 0.0 --
2012  A -2.3 -16.7 -- 0.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
Acrux Limited (ACR) $196 M 3.0384 -0.3607 1.2337 6.9940 10.9404 4.8979 6.81 5.87 5.51
Immuron (IMC) $16 M -- -- -- -- -- -- 0.00 -- --
Mayne Pharma Group (MYX) $360 M 1.0457 -0.1821 0.6250 19.4888 23.8281 14.6635 0.00 0.00 0.00

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
IMC -- -- 1.99 -- 7.20
Market 1.02 13.7 0.96 0.99 2.90
Sector 0.81 16.3 2.51 1.44 7.24

Directors
Name Position Start Date
Dr Roger Aston Non-Executive Chairman 25 May 2012
Mr Daniel Pollock Non-Executive Director 11 October 2012
Mr Stephen Anastasiou Non-Executive Director 28 May 2013

Management
Name Position
Amos Meltzer Chief Executive Officer
Graeme Stevens Company Secretary and Chief Financial Officer
Phillip Hains Joint Company Secretary
Peter Vaughan Joint Company Secretary

Substantial Shareholders
Holding Name
59,164,094 (5.71%) Hadasit Medical Research Services & Development Ltd
168,326,929 (16.56%) Grandlodge Pty Ltd
54,627,723 (5.38%) Capital Concerns Pty Limited <Logue Family Super Fund>
146,576,329 (14.42%) David Plush and Texas Woods Pty Ltd

Calendar of Events
Date Event
28 August 2015 Report (Annual)
28 August 2015 Report (Prelim)
27 February 2015 Report (Interim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Investing in Art

An educational booklet with useful, practical tips to help you make better-informed decisions about investing in art.

More details...

News

Markets melt up

By Michael McCarthy (chief market strategist, CMC Markets) 19/12/2014 | Traders and investors caught short heading into the FOMC scrambled for cover in Europe and the US, in many cases driving indices to their best one day performance for 2015.

Aussie Investors take their foot off the accelerator

By Betty Lam (Sales Trader, CMC Markets) 18/12/2014 | Lead by the Fed-fervour offshore, Australians shares jumped on the Yellen cheer wagon. The material and energy stocks were back in vogue as both sectors gained over 3% in morning trade.

Fed Feeds Frenzy

By Michael McCarthy (chief market strategist, CMC Markets) 18/12/2014 | In spite of a frenzied pre-mortem, a benign statement from the US Federal Reserve’s Open Market Committee and steadying commodity markets drove investors back into share markets overnight. A calmer, stronger ruble helped offset European growth fears, highlighted in the overnight session by further declines in inflation.

Household brands Woolworths and Telstra Heavy Lifting

By Betty Lam (Sales Trader, CMC Markets) 11/12/2014 | Offshore jitters sent ripples through to Australian stocks. The open saw the local equities take 65 points off the index, catalysed by a mass-exit in energy stocks, yet again.

Steady open as Woodside investors wait on details of possible Wheatstone acquisition

By Ric Spooner (Chief Market Analyst, CMC Markets) 10/12/2014 | Yesterday’s news on Greek politics and China’s bond market came at a time when US and European stock markets have extended rallies and pushed valuations higher. This makes those markets vulnerable to downward corrections as profit takers act to avoid missing out.

MYEFO and Lima - December could be nasty.

BR Securities Australia Pty Ltd 2/12/2014 | December 2014 could go down as a nasty moment in Australian finance. MYEFO will reveal a deteriorating budget deficit and the UNFCCC meeting in Lima, Peru will provide the agreement, to be ratified in Paris in 2015, on how much (or little) CO2 is to be allowed into the atmosphere from 2020.

More...


Sponsored Links